# Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

> **NCT00048750** · PHASE3 · TERMINATED · sponsor: **Astellas Pharma Inc** · enrollment: 104 (actual)

## Conditions studied

- Invasive Fungal Infections

## Interventions

- **DRUG:** Micafungin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00048750
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 104 (ACTUAL)
- **Why stopped:** Inadequate enrollment
- **Last updated:** 2012-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048750, "Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00048750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*